Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/1996
11/12/1996US5573939 DNA encoding mammalian retinol binding protein receptor, and corresponding vectors and transformed cells
11/12/1996US5573935 Protein tyrosine kinase A6
11/12/1996US5573924 Novel receptor cytokine, protein
11/12/1996US5573920 Antibodies, and methods for their use
11/12/1996US5573918 Process and reagent for specific determination of pancreatic alpha amylase
11/12/1996US5573904 5(6)-Methyl substituted fluorescein derivatives
11/12/1996US5573767 Lutenizing hormone-releasing hormone
11/12/1996US5573763 Family of CSF-l proteins
11/12/1996US5573762 Use of leukemia inhibitory factor specific antibodies and endothelin antagonists for treatment of cardiac hypertrophy
11/12/1996CA1338721C Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
11/12/1996CA1338706C Monoclonal anti-human breast cancer antibodies suitable for imaging breast cancer
11/07/1996WO1996034970A1 Improved methods for transfecting t cells
11/07/1996WO1996034964A2 Stable variant hk2 polypeptide
11/07/1996WO1996034957A1 Pancreas-derived serpin
11/07/1996WO1996034951A1 Gdu, a novel signalling protein
11/07/1996WO1996034948A1 Monoclonal antibody reactive with human-origin cetp and method of quantifying human-origin cetp
11/07/1996WO1996034940A1 Dna encoding glutamate gated chloride channels
11/07/1996WO1996034892A1 Bispecific antibodies in which the binding capability is reversibly inhibited by a photocleavable moiety
11/07/1996WO1996034891A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996WO1996034888A1 Modulation of cholesteryl ester transfer protein (cetp) activity
11/07/1996WO1996034880A1 Cd6 ligand
11/07/1996WO1996034877A1 Human neuropeptide receptor
11/07/1996WO1996034630A1 Conjugates of folate and anti-effector cell antibodies
11/07/1996WO1996034627A1 Murine and human box-dependent myc-interacting protein (bin1) and uses therefor
11/07/1996WO1996034625A1 Recombinant vesiculoviruses and their uses
11/07/1996WO1996034624A1 Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
11/07/1996WO1996034616A1 Serum preparations for inhibiting retroviruses and tumor growth
11/07/1996WO1996030520A3 Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
11/07/1996WO1996027664A3 Antisense transcript expressed in b lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof
11/07/1996CA2220123A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996CA2220098A1 Cd6 ligand
11/07/1996CA2220036A1 Human neuropeptide receptor
11/07/1996CA2220016A1 Gdu, a novel signalling protein
11/07/1996CA2219899A1 Shark serum preparations for inhibiting retroviruses and tumor growth
11/07/1996CA2219775A1 Murine and human box-dependent myc-interacting protein (bin1) and uses therefor
11/07/1996CA2218034A1 Pancreas-derived serpin
11/06/1996EP0741144A1 Antiannexin-v monoclonal antibody, process for producing the same, and use therof
11/06/1996EP0740703A1 Diagnosis and treatment of infections due to streptococci and enterococci
11/06/1996EP0740553A1 Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells
11/06/1996EP0413763B1 Method for the production of monoclonal antibodies utilizing a germfree animal
11/06/1996CN1135237A Products that elicit neutralizing antibodies against genetically divergent HIV-1 strains
11/05/1996US5571905 Gene mutated in colorectal cancer of humans
11/05/1996US5571895 Modified GAF polypeptides
11/05/1996US5571894 Recombinant antibodies specific for a growth factor receptor
11/05/1996US5571786 Analgesics and antiinflammatory agents
11/05/1996US5571714 Treatment of acute liver injury
11/05/1996US5571710 CDNA coding for carcinoembryonic antigen
11/05/1996US5571708 Thrombin-activatable plasminogen activator
11/05/1996US5571702 Amplification method for detection of human PF4A receptors
11/05/1996US5571681 Chemical event selection by suicide substrate conjugates
11/05/1996US5571679 Antiinflammatory agents and immunoassay
11/05/1996US5571678 Placental isoferritins for the prognosis and diagnosis of immunosuppression
11/05/1996US5571675 Detection and amplification of candiotrophin-1(cardiac hypertrophy factor)
11/05/1996US5571515 Compositions and methods for use of IL-12 as an adjuvant
11/05/1996US5571513 Which specifically binds to extracellular domain of human cytokine receptor
11/05/1996US5571512 Pharmaceutical composition against AIDS
11/05/1996US5571511 Broadly reactive opsonic antibodies that react with common staphylococcal antigens
11/05/1996US5571509 Protein
11/05/1996US5571068 Centrifuge assembly
10/1996
10/31/1996WO1996034117A1 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene kai1
10/31/1996WO1996034107A2 Antiviral proteins, dna coding sequences therefor, and uses thereof
10/31/1996WO1996034106A1 Decorin binding protein compositions and methods of use
10/31/1996WO1996034103A1 Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
10/31/1996WO1996034100A1 Immortalised cell lines from human adipose tissue, process for preparing same and applications thereof
10/31/1996WO1996034099A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor
10/31/1996WO1996034096A1 Human antibodies derived from immunized xenomice
10/31/1996WO1996034088A2 Control of floral induction in plants and uses therefor
10/31/1996WO1996034015A1 Modified anti-icam-1 antibodies and their use in the treatment of inflammation
10/31/1996WO1996034005A1 Synthesis of the breast tumor-associated antigen defined by monoclonal antibody mbr1 and uses thereof
10/31/1996WO1996033740A1 Use of leukemia inhibitory factor and endothelin antagonists
10/31/1996WO1996033735A1 Human antibodies derived from immunized xenomice
10/31/1996CA2761116A1 Human antibodies derived from immunized xenomice
10/31/1996CA2219996A1 Immortalised cell lines from human adipose tissue, process for preparing same and applications thereof
10/31/1996CA2219486A1 Human antibodies derived from immunized xenomice
10/31/1996CA2219221A1 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene kai1
10/31/1996CA2219214A1 Genetic sequences and proteins related to alzheimer's disease, and uses therefor
10/31/1996CA2219105A1 Cyanovirin-n, an anti-hiv protein, dna coding sequences therefor, and uses thereof
10/31/1996CA2218492A1 Decorin binding protein compositions and methods of use
10/31/1996CA2214500A1 Control of floral induction in plants and uses therefor
10/30/1996EP0739984A1 Bivalent polypeptides containing at least two domains
10/30/1996EP0739981A1 Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
10/30/1996EP0739904A1 Bispecific reagents for aids therapy
10/30/1996EP0739488A1 Antagonists to insulin receptor tyrosine kinase inhibitor
10/30/1996EP0739419A1 Methods of assaying dna-repairing enzymes and their alkylated derivatives
10/30/1996EP0739413A1 Method of selecting specific bacteriophages
10/30/1996EP0739356A1 Polyclonal antibody to pna/nucleic acid complexes
10/30/1996EP0739350A1 Ligand that binds fas antigen
10/30/1996EP0739214A1 A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS
10/30/1996EP0739211A1 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope
10/30/1996EP0647277A4 Methods for using cks fusion proteins.
10/30/1996EP0600951A4 Diagnostic method for alzheimer's disease.
10/30/1996EP0512071B1 Method and compositions for inhibiting angiogenesis
10/30/1996EP0479909B1 Bispecific reagents for aids therapy
10/30/1996CN1134704A Drug binding protein
10/29/1996US5569825 Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
10/29/1996US5569673 Capsacinoid compounds as proliferation inhibitors
10/29/1996US5569603 Parasiticide
10/29/1996US5569602 First immortalized Kaposi's sarcoma cell line
10/29/1996US5569600 Reacting heparin or heparin sulfate with purified heparinase present in flavobacterium heparium free of lyase activity
10/29/1996US5569585 Stimulating non-resting immune cells to activity: stimulant dosage will activate primed cells but does not stimulate resting cells; measurement
1 ... 1325 1326 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 ... 1494